Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Benefits for Stakeholders

1.3. Key Market Segments

1.3.1. List of key players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Market Share Analysis, 2017 (%)

3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase in the incidence rate of diabetes

3.4.1.2. Rise in geriatric population

3.4.1.3. Technological advancements in diabetes monitoring devices

3.4.1.4. Rise in risk factors that lead to diabetes

3.4.2. Restraints

3.4.2.1. Inaccurate results

3.4.3. Opportunity

3.4.3.1. Increase in awareness for diabetes monitoring devices

3.4.3.2. Untapped market opportunities in the developing regions

3.4.4. Impact analyses

CHAPTER 4: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast, by product

4.2. Test Strips

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.3. Lancets

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis, by country

4.4. Blood Glucose Meters

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market analysis, by country

CHAPTER 5: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast, by revenue

5.2. Type 1 Diabetes

5.2.1. Market size and forecast, by region

5.2.2. Market analysis, by country

5.3. Type 2 diabetes

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Gestational Diabetes

5.4.1. Market size and forecast, by region

5.4.2. Market analysis, by country

CHAPTER 6: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by country

6.3. Home Settings

6.3.1. Market size and forecast, by region

6.3.2. Market analysis, by country

6.4. Diagnostic Centers

6.4.1. Market size and forecast, by region

6.4.2. Market analysis, by country

CHAPTER 7: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities

7.2.2. North America market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. market size and forecast, by product

7.2.2.1.2. U.S. market size and forecast, by application

7.2.2.1.3. U.S. market size and forecast, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada market size and forecast, by product

7.2.2.2.2. Canada market size and forecast, by application

7.2.2.2.3. Canada market size and forecast, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico market size and forecast, by product

7.2.2.3.2. Mexico market size and forecast, by application

7.2.2.3.3. Mexico market size and forecast, by end user

7.2.3. North America market size and forecast, by product

7.2.4. North America market size and forecast, by application

7.2.5. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Europe self-monitoring blood glucose devices market, by country

7.3.2.1. Germany

7.3.2.1.1. Germany market size and forecast, by product

7.3.2.1.2. Germany market size and forecast, by application

7.3.2.1.3. Germany market size and forecast, by end user

7.3.2.2. France

7.3.2.2.1. France market size and forecast, by product

7.3.2.2.2. France market size and forecast, by application

7.3.2.2.3. France market size and forecast, by end user

7.3.2.3. UK

7.3.2.3.1. UK market size and forecast, by product

7.3.2.3.2. UK market size and forecast, by application

7.3.2.3.3. UK market size and forecast, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy market size and forecast, by product

7.3.2.4.2. Italy market size and forecast, by application

7.3.2.4.3. Italy market size and forecast, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain market size and forecast, by product

7.3.2.5.2. Spain market size and forecast, by application

7.3.2.5.3. Spain market size and forecast, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe market size and forecast, by product

7.3.2.6.2. Rest of Europe market size and forecast, by application

7.3.2.6.3. Rest of Europe market size and forecast, by end user

7.3.3. Europe market size and forecast, by product

7.3.4. Europe market size and forecast, by application

7.3.5. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Asia-Pacific market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan market size and forecast, by product

7.4.2.1.2. Japan market size and forecast, by application

7.4.2.1.3. Japan market size and forecast, by end user

7.4.2.2. China

7.4.2.2.1. China market size and forecast, by product

7.4.2.2.2. China market size and forecast, by application

7.4.2.2.3. China market size and forecast, by end user

7.4.2.3. India

7.4.2.3.1. India market size and forecast, by product

7.4.2.3.2. India market size and forecast, by application

7.4.2.3.3. India market size and forecast, by end user

7.4.2.4. Australia

7.4.2.4.1. Australia market size and forecast, by product

7.4.2.4.2. Australia market size and forecast, by application

7.4.2.4.3. Australia market size and forecast, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea market size and forecast, by product

7.4.2.5.2. South Korea market size and forecast, by application

7.4.2.5.3. South Korea market size and forecast, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product

7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application

7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user

7.4.3. Asia-Pacific market size and forecast, by product

7.4.4. Asia-Pacific market size and forecast, by application

7.4.5. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. LAMEA market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil market size and forecast, by product

7.5.2.1.2. Brazil market size and forecast, by application

7.5.2.1.3. Brazil market size and forecast, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia market size and forecast, by product

7.5.2.2.2. Saudi Arabia market size and forecast, by application

7.5.2.2.3. Saudi Arabia market size and forecast, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Arica market size and forecast, by product

7.5.2.3.2. South Arica market size and forecast, by application

7.5.2.3.3. South Arica market size and forecast, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Rest of LAMEA market size and forecast, by product

7.5.2.4.2. Rest of LAMEA market size and forecast, by application

7.5.2.4.3. Rest of LAMEA market size and forecast, by end user

7.5.3. LAMEA market size and forecast, by product

7.5.4. LAMEA market size and forecast, by application

7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Abbott Laboratories

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product Portfolio

8.1.5. Business performance

8.1.6. Key strategic moves and developments

8.2. Becton, Dickinson and Company

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Product Portfolio

8.2.5. Business performance

8.2.6. Key strategic moves and developments

8.3. B. Braun Melsungen AG

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product Portfolio

8.3.5. Business performance

8.3.6. Key strategic moves and developments

8.4. F. Hoffmann-La Roche Ltd.

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.4.6. Key strategic moves and developments

8.5. Johnson & Johnson

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product Portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

8.6. Medtronic plc

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product Portfolio

8.6.5. Business performance

8.6.6. Key strategic moves and developments

8.7. PHC Holdings Corporation

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Key strategic moves and developments

8.8. Sanofi

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product Portfolio

8.8.5. Business performance

8.8.6. Key strategic moves and developments

8.9. Terumo Corporation

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product Portfolio

8.9.5. Business performance

8.10. Trividia Health, Inc.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

LIST OF TABLES

TABLE 01. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 02. SELF-MONITORING BLOOD GLUCOSE TEST STRIPS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 03. SELF-MONITORING BLOOD GLUCOSE LANCETS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 04. SELF-MONITORING BLOOD GLUCOSE METERS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 05. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 06. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, BY REGION, 2017-2025 ($MILLION)

TABLE 07. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, BY REGION, 2017-2025 ($MILLION)

TABLE 08. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, BY REGION, 2017-2025 ($MILLION)

TABLE 09. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)

TABLE 10. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, BY REGION, 2017-2025 ($MILLION)

TABLE 11. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, BY REGION, 2017-2025 ($MILLION)

TABLE 12. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2017-2025 ($MILLION)

TABLE 13. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 14. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 15. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 16. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 17. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 18. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 19. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 20. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 21. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 22. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 23. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 24. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 25. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 26. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 27. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 28. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 29. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 30. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 31. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 32. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 33. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 34. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 35. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 36. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 37. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 38. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 39. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 40. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 41. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 42. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 43. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 44. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 45. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 46. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 47. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 48. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 49. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 50. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 51. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 52. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 53. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 54. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 55. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 56. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 57. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 58. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 59. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 60. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 61. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 62. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 63. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 64. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 65. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 66. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 67. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 68. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 69. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 70. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 71. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 72. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 73. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 74. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 75. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 76. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 77. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 78. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 79. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 80. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 81. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 82. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 83. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 84. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 85. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 86. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 87. ABBOTT: COMPANY SNAPSHOT

TABLE 88. ABBOTT: OPERATING SEGMENTS

TABLE 89. ABBOTT: PRODUCT PORTFOLIO

TABLE 90. BD: COMPANY SNAPSHOT

TABLE 91. BD: BUSINESS SEGMENTS

TABLE 92. BD: PRODUCT PORTFOLIO

TABLE 93. B. BRAUN: COMPANY SNAPSHOT

TABLE 94. B. BRAUN: OPERATING SEGMENTS

TABLE 95. B. BRAUN: PRODUCT PORTFOLIO

TABLE 96. ROCHE: COMPANY SNAPSHOT

TABLE 97. ROCHE: OPERATING SEGMENTS

TABLE 98. ROCHE: PRODUCT PORTFOLIO

TABLE 99. J&J: COMPANY SNAPSHOT

TABLE 100. J&J: OPERATING SEGMENTS

TABLE 101. J&J: PRODUCT PORTFOLIO

TABLE 102. MEDTRONIC: COMPANY SNAPSHOT

TABLE 103. MEDTRONIC: OPERATING SEGMENTS

TABLE 104. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 105. PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT

TABLE 106. PHC HOLDINGS CORPORATION: BUSINESS SEGMENTS

TABLE 107. PHC HOLDINGS CORPORATION: PRODUCT PORTFOLIO

TABLE 108. SANOFI: COMPANY SNAPSHOT

TABLE 109. SANOFI: OPERATING SEGMENTS

TABLE 110. SANOFI: PRODUCT PORTFOLIO

TABLE 111. TERUMO: COMPANY SNAPSHOT

TABLE 112. TERUMO: OPERATING SEGMENTS

TABLE 113. TERUMO: PRODUCT PORTFOLIO

TABLE 114. TRIVIDIA HEALTH, INC.: COMPANY SNAPSHOT

TABLE 115. TRIVIDIA HEALTH, INC.: PRODUCT SEGMENTS

TABLE 116. TRIVIDIA HEALTH, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2017*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2017* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2017*

FIGURE 06. MARKET SHARE ANALYSIS, 2017

FIGURE 07. PERCENTAGE OF POPULATION AGED 65 AND OVER ACROSS THE WORLD: 2015 AND 2050

FIGURE 08. IMPACT ANALYSES

FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE TEST STRIPS MARKET FOR BRACKETS, 2017 & 2025 (%)

FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE LANCETS MARKET, 2017 & 2025 (%)

FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE METERS MARKET, 2017 & 2025 (%)

FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, 2017 & 2025 (%)

FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, 2017 & 2025 (%)

FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, 2017 & 2025 (%)

FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, 2017 & 2025 (%)

FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, 2017 & 2025 (%)

FIGURE 17. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, 2017 & 2025 (%)

FIGURE 18. ABBOTT: NET SALES, 2015-2017 ($MILLION)

FIGURE 19. ABBOTT: NET SALES SHARE BY SEGMENT, 2017 (%)

FIGURE 20. ABBOTT: NET SALES SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 21. BD: NET SALES, 2015-2017 ($MILLION)

FIGURE 22. BD: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 23. BD: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 24. NET SALES, 2015-2017 ($MILLION)

FIGURE 25. B. BRAUN: NET SALES BY SEGMENT, 2017 (%)

FIGURE 26. B. BRAUN: NET SALES BY GEOGRAPHY, 2017 (%)

FIGURE 27. ROCHE: NET SALES, 2015-2017 ($MILLION)

FIGURE 28. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 29. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 30. J&J: NET SALES, 2015-2017 ($MILLION)

FIGURE 31. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 32. J&J: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 33. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)

FIGURE 34. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)

FIGURE 35. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2017 (%)

FIGURE 36. SANOFI: NET SALES, 2015-2017 ($MILLION)

FIGURE 37. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 38. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 39. TERUMO: NET SALES, 2015-2017 ($MILLION)

FIGURE 40. TERUMO: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 41. TERUMO: REVENUE SHARE BY GEOGRAPHY, 2017 (%)